Primary Site >> Liver Cancer

Gene >> TPX2

Journal: Curr Biol. 2006 Apr 18;16(8):743-54.
Title: HURP is part of a Ran-dependent complex involved in spindle formation.
Author: Koffa, Maria D|Casanova, Claudia M|Santarella, Rachel|Kocher, Thomas|Wilm, Matthias|Mattaj, Iain W
PMID: 16631581
Journal: Clin Cancer Res. 2010 May 1;16(9):2518-28.
Title: Combined functional genome survey of therapeutic targets for hepatocellular carcinoma.
Author: Satow, Reiko|Shitashige, Miki|Kanai, Yae|Takeshita, Fumitaka|Ojima, Hidenori|Jigami, Takafumi|Honda, Kazufumi|Kosuge, Tomoo|Ochiya, Takahiro|Hirohashi, Setsuo|Yamada, Tesshi
PMID: 20388846
Journal: Onco Targets Ther. 2014 Jun 13;7:1061-70.
Title: HCA519/TPX2: a potential T-cell tumor-associated antigen for human hepatocellular carcinoma.
Author: Aref, Ahmed M|Hoa, Neil T|Ge, Lisheng|Agrawal, Anshu|Dacosta-Iyer, Maria|Lambrecht, Nils|Ouyang, Yi|Cornforth, Andrew N|Jadus, Martin R
PMID: 24966688
Journal: Chin J Cancer Res. 2014 Aug;26(4):410-7.
Title: TPX2 knockdown suppressed hepatocellular carcinoma cell invasion via inactivating AKT signaling and inhibiting MMP2 and MMP9 expression.
Author: Liu, Qingquan|Yang, Pinghua|Tu, Kangsheng|Zhang, Hongyong|Zheng, Xin|Yao, Yingmin|Liu, Qingguang
PMID: 25232213
Journal: Int J Mol Sci. 2014 Oct 9;15(10):18148-61.
Title: TPX2 is a prognostic marker and contributes to growth and metastasis of human hepatocellular carcinoma.
Author: Huang, Yuqi|Guo, Wenbin|Kan, Heping
PMID: 25302620
Journal: Hepatol Res. 2015 Aug;45(8):906-18.
Title: TPX2 as a novel prognostic biomarker for hepatocellular carcinoma.
Author: Liu, Qingquan|Tu, Kangsheng|Zhang, Hongyong|Zheng, Xin|Yao, Yingmin|Liu, Qingguang
PMID: 25263743
Journal: Zhonghua Yi Xue Za Zhi. 2015 Feb 10;95(6):408-11.
Title: [Expression of TPX2 in hepatocellular carcinoma and its clinical significance].
Author: Liang, Bo|Huang, Yu|He, Hua|Li, Jialu|Liao, Hui|Liu, Xincheng|Guo, Botang|Yang, Dinghua
PMID: 25916774
Journal: J Cancer. 2017 May 12;8(8):1378-1394.
Title: Targeting TPX2 Suppresses the Tumorigenesis of Hepatocellular Carcinoma Cells Resulting in Arrested Mitotic Phase Progression and Increased Genomic Instability.
Author: Hsu, Chao-Wen|Chen, Yu-Chia|Su, Hsing-Hao|Huang, Guan-Jin|Shu, Chih-Wen|Wu, Tony Tong-Lin|Pan, Hung-Wei
PMID: 28638452
Journal: Cancer Lett. 2018 Feb 1;414:71-80.
Title: AGBL2 promotes cancer cell growth through IRGM-regulated autophagy and enhanced Aurora A activity in hepatocellular carcinoma.
Author: Wang, Li-Li|Jin, Xiao-Han|Cai, Mu-Yan|Li, Hai-Gang|Chen, Jie-Wei|Wang, Feng-Wei|Wang, Chen-Yuan|Hu, Wei-Wei|Liu, Fang|Xie, Dan
PMID: 29126912
Journal: Onco Targets Ther. 2018 Mar 21;11:1601-1616.
Title: Targeting DTL induces cell cycle arrest and senescence and suppresses cell growth and colony formation through TPX2 inhibition in human hepatocellular carcinoma cells.
Author: Chen, Yu-Chia|Chen, I-Shu|Huang, Guan-Jin|Kang, Chi-Hsiang|Wang, Kuo-Chiang|Tsao, Min-Jen|Pan, Hung-Wei
PMID: 29606879
Journal: Front Physiol. 2018 Jul 27;9:1019.
Title: Dysfunction of Sister Chromatids Separation Promotes Progression of Hepatocellular Carcinoma According to Analysis of Gene Expression Profiling.
Author: Sun, Baozhen|Lin, Guibo|Ji, Degang|Li, Shuo|Chi, Guonan|Jin, Xingyi
PMID: 30100882